Susanna Malmström Ph.D, promoted to Director of Alliances
CILcare is pleased to announce the promotion of Susanna Malmström to the position of Director of Alliances. Research expert in the inner ear, Dr. Malmström has played a significant role…
How to assess drug candidates on tinnitus preclinical models for a successful transition to clinical trials ?
Sylvie Pucheu will be presenting a webinar on preclinical tinnitus models on July 9, 2020: Tinnitus is one of the most common hearing disorders, for which there is no…
CILcare extends its expertise to develop solutions for people with vestibular disorders with its partner Vertidiag
CILcare, world leading CRO entirely specialized in the field of hearing disorders, announces a strategic partnership with the start-up Vertidiag, a company specialized in balance disorders. By combining their unique…
Multiple drugs tested against Covid-19 are listed among ototoxic agents
Contact our team to know more about studies we can conduct to assess both hearing impairment and tinnitus
CILcare announced among the winners of EIT Health’s Bridgehead Global 2020 program !
CILcare announced among the winners of EIT Health’s Bridgehead Global 2020 program Montpellier, 4 June 2020: CILcare, the world’s leading CRO specialized in the field of hearing, is one…
Dementia & hearing loss are closely related
Contact our team to know more about studies we can conduct to assess both hearing and cognitive parameters.
